Methylene Blue-Based Combination Therapy with Amodiaquine Prevents Severe Malaria in an Experimental Rodent Model

Untreated malaria can progress rapidly to severe forms (<24 h). Moreover, resistance to antimalarial drugs is a threat to global efforts to protect people from malaria. Given this, it is clear that new chemotherapy must be developed. We contribute new data about using methylene blue (MB) to cure...

Descripción completa

Detalles Bibliográficos
Autores principales: Dormoi, Jérôme, Amalvict, Rémy, Gendrot, Mathieu, Pradines, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611243/
https://www.ncbi.nlm.nih.gov/pubmed/36297466
http://dx.doi.org/10.3390/pharmaceutics14102031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611243/
https://www.ncbi.nlm.nih.gov/pubmed/36297466
http://dx.doi.org/10.3390/pharmaceutics14102031

Ejemplares similares